COVID-19: England cuts isolation period to 7 days for positive cases

COVID-19: England reduced to 7 days in period ; isolation for positive cases

MISE & Agrave; DAY

LONDON | The British government on Wednesday reduced the isolation period in England from 10 to 7 days for those vaccinated with the coronavirus, amid the surge in Omicron cases and to two days before Christmas Eve.

Starting Wednesday, people who have two negative antigen tests from days six and seven will be able to recover from their isolation. & nbsp;

According to the government, this will allow more people to spend Christmas with their families, without risking transmitting the virus. According to Secretary of State for Health Gillian Keegan, “the risk is equivalent” of being released from isolation after seven days “if you have two negative tests” compared to “waiting three more days in your room”, she said Wednesday morning on Sky news. & nbsp;

“If you have tested positive or presented your first symptoms on Saturday 18 (December), you will be able to enjoy your Christmas meal” with your family, she congratulated on Times Radio, “assuming your antigen test is negative the sixth and seventh days ”. & nbsp;

This relaxation of the rules comes as the United Kingdom, the country among the most affected by the pandemic in Europe with more than 147,000 deaths, has been facing for some time a spike in cases (+90.629 Tuesday) due to the highly contagious Omicron variant. & nbsp;

However, British Prime Minister Boris Johnson once again ruled out any new restrictions in England before Christmas on Tuesday. & Nbsp;

Wales, which like every British province decides on its health policy, announced to him that from December 26, groups would be limited to a maximum of six people in pubs, restaurants and cinemas. & nbsp;

The service must be at the table and events will be limited to 50 people outside, 30 inside, said Welsh Prime Minister Mark Drakeford. & Nbsp;

British Minister for Health Sajid Javid on Wednesday announced the signing of two new contracts with Merck and Pfizer, from which the United Kingdom is buying 1.75 million and 2.5 million additional tablets of their anti-COVID antivirals – respectively molnupiravir and PF-07321332/ritonavir.

Antivirals work by reducing the ability of a virus to replicate, thereby slowing down disease. These tablet treatments can be taken at home and are a new essential weapon in the fight against the disease. & Nbsp;

See also & nbsp;

Share Button